Together these data support a role for altered activation of the Oxidation pathway specifically the KEAP1-NRF2 pathway in not only recurrent laryngeal tumors, but also in Head and Neck cancers more broadly, and these results warrant further investigation in additional cohorts. The gene discussed is KEAP1; the disease is head and neck cancer.